本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Century Therapeutics, Inc.

2.07
+0.05002.48%
盤後2.130.0600+2.90%19:30 EDT
成交量:33.06萬
成交額:68.04萬
市值:3.75億
市盈率:-2.23
高:2.09
開:2.05
低:2.02
收:2.02
52周最高:3.04
52周最低:0.4350
股本:1.81億
流通股本:1.01億
量比:0.80
換手率:0.33%
股息:- -
股息率:- -
每股收益(TTM):-0.9300
每股收益(LYR):-0.1107
淨資產收益率:-49.65%
總資產收益率:-23.51%
市淨率:1.61
市盈率(LYR):-18.70

資料載入中...

公司資料

公司名字:
Century Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2018
員工人數:
78
公司地址:
25 North 38th Street,11th Floor,Philadelphia,Pennsylvania,United States
郵編:
19104
電話:
傳真:
- -
簡介:
Century Therapeutics, Inc.於2018年3月5日在特拉華州註冊成立。該公司是一家專註於開發用於自身免疫性疾病和癌症的異體多能幹細胞療法的生物技術公司。其平台利用誘導多能幹細胞生成多種細胞類型,包括胰島β細胞和免疫細胞,並通過專有技術進行工程化改造以防止宿主免疫排斥。

董事

名稱
職位
Brent Pfeiffenberger
Director,President and Chief Executive Officer,Chairman of the Board
Alessandro Riva
Independent Director
Daphne E. Quimi
Independent Director
Kimberly Blackwell
Independent Director
Timothy P. Walbert
Independent Director
Han Lee
Director
Martin Murphy
Director

股東

名稱
職位
Brent Pfeiffenberger
Director,President and Chief Executive Officer,Chairman of the Board
Douglas Carr
Senior Vice President, Finance,Interim Principal Financial Officer
Chad Cowan
Chief Scientific Officer
Gregory Russotti
Chief Technology and Manufacturing Officer
Hyam Levitsky
President of Research and Development